International Stem Cell Corporation Grant... - Cure Parkinson's

Cure Parkinson's

26,957 members28,376 posts

International Stem Cell Corporation Granted Key US Patent Protecting Lead Therapeutic Program

Farooqji profile image
5 Replies

The patent covers the use of ISC-hpNSC®, ISCO’s proprietary neural stem cells derived from human parthenogenetic stem cells, for the treatment of neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease and amyotrophic lateral sclerosis. This patent also covers the use of neural cells derived from other human pluripotent stem cell sources, such as human embryonic stem cells (hESC) and induced pluripotent stem (iPS) cells.

globenewswire.com/news-rele...

Written by
Farooqji profile image
Farooqji
To view profiles and participate in discussions please or .
Read more about...
5 Replies
jeffreyn profile image
jeffreyn

I found the title, but I can't find the patent itself:

US10039794 - Use of neural cells derived from human pluripotent stem cells for the treatment of human neurodegenerative diseases.

Anyone else have more luck?

Farooqji profile image
Farooqji in reply tojeffreyn

patents.google.com/patent/U...

jeffreyn profile image
jeffreyn in reply toFarooqji

But this is a link to a patent titled "Method of converting digital data" ???

jeffreyn profile image
jeffreyn in reply tojeffreyn

I think I've got it now:

patents.justia.com/patent/1...

jeffreyn profile image
jeffreyn

For anyone who might like some background information:

globenewswire.com/news-rele...

(this news release contains a link to a research paper)

Not what you're looking for?

You may also like...

More Stem Cell Success!

A new therapeutic approach in which patient-derived dopamine-producing neurons are transplanted...
jimcaster profile image

Method generates dopaminergic neurons lost in Parkinson’s disease

"Forget The Mice, Just Fast Track for Patients". Mice the winners again. Researchers in Canada...
Baron1 profile image

Stem Cells Trials

I want to make a list here. Please reply with links...

Allogeneic Bone Marrow–Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson's Disease

Credit to @[1619734] and @[1511265] ! Allogeneic Bone Marrow–Derived Mesenchymal Stem Cell Safety...

International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson's Disease Clinical Trial

Interim results of this study will be presented at the upcoming 2019 American Academy of Neurology...
Farooqji profile image